Outcomes | Combination group (n = 32), n (%) | Chemotherapy group (n = 64), n (%) | P value |
---|---|---|---|
Best tumor response | |||
Complete response | 0 (0%) | 0 (0%) | |
Partial response | 9 (28.1) | 14 (21.9) | 0.499 |
Stable disease | 20 (62.5) | 36 (56.3) | 0.558 |
Progressive disease | 3 (9.4) | 14 (21.9) | 0.163 |
Objective response rate | 9 (28.1) | 14 (21.9) | 0.499 |
Disease control rate | 29 (90.6) | 50 (78.1) | 0.163 |
Median OS (mo)* | 22.3 ± 2.9 (16.6–28.0) | 18.6 ± 2.7 (13.3–23.9) | 0.031 |
Median PFS (mo)* | 12.0 ± 3.1 (5.8–18.1) | 10.5 ± 2.2 (6.3–14.7) | 0.043 |